SCHEMBL22567795

SCHEMBL22567795

CC(C)(C)c1ccc(-c2ccc(N)c(-c3ccccc3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.48
▸ DHODH Q02127 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ LMNA P02545 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ KIF11 P52732 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ ALOX12 P18054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5715974 0.88 NPC1 (0.47) S1PR1ALDH1A1LMNANPC1RAB9A
SCHEMBL16415371 0.87 ALDH1A1 (0.48) S1PR1ALDH1A1HSD17B10LMNANPC1
SCHEMBL29573094 0.87 ALDH1A1 (0.48) S1PR1ALDH1A1HSD17B10LMNANPC1
Biphenyl SCHEMBL28547831 0.85 ALDH1A1 (0.58) ALDH1A1HSD17B10LMNANPC1RAB9A
SCHEMBL22567844 0.85 ALDH1A1 (0.58) ALDH1A1HSD17B10LMNANPC1RAB9A
SCHEMBL2835861 0.85 ALDH1A1 (0.58) ALDH1A1HSD17B10LMNANPC1RAB9A
SCHEMBL31097230 0.85 KIF11 (0.45) S1PR1DHODHALDH1A1HSD17B10LMNA
SCHEMBL23432313 0.83 NPC1 (0.49) S1PR1ALDH1A1HSD17B10LMNANPC1
SCHEMBL29911234 0.83 NPC1 (0.49) S1PR1ALDH1A1HSD17B10LMNANPC1
Hydrochloric Acid SCHEMBL27938939 0.83 ALDH1A1 (0.56) ALDH1A1HSD17B10LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844270-B2 Compound and organic light emitting device including the same LG DISPLAY CO., LTD. (KR) 2023-12-12 — — US disclosed
US-11844270-B2 Compound and organic light emitting device including the same LG DISPLAY CO., LTD. (KR) 2023-12-12 — — US disclosed
US-20230320215-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-05 — — US disclosed
US-20230320215-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-05 — — US disclosed
US-20230320215-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-05 — — US disclosed
US-20200335698-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE LG DISPLAY CO., LTD. (KR) 2020-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11844270-B2 Compound and organic light emitting device including the same TMEM109, CRY1, VDAC1 S1PR1 4113/4885DHODH 1010/4885ALDH1A1 54/4885
US-20230320215-A1 LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE CRY1, LAGE3, CRY2 S1PR1 4770/4885DHODH 3184/4885ALDH1A1 25/4885
US-20200335698-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE TMEM109, TRPC1, MAP1LC3B S1PR1 4319/4885DHODH 1750/4885ALDH1A1 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback